RxDoctor Payments Data

Walter Wardell, MD

Internal Medicine · Havelock, NCNPI 1538111851

Payments from drug & device makers

$1,637in general payments, 2019–2025

Across 88 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$283
  • AbbVie$265
  • Johnson & Johnson$238
  • Lilly USA, LLC$162
  • Novo Nordisk$147
  • Novartis$85
  • plus $457 from 13 others

What the payments were for

  • Food & beverage$1,637100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,637 in reported general payments places this provider in the 75th percentile of 3,302 internal medicine providers in North Carolina.

See all internal medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$200,662
Medicare patients
437
Services billed
9,090

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide77$143,525
EliquisApixaban55$67,429
MounjaroTirzepatide16$26,394
JardianceEmpagliflozin19$22,433
XareltoRivaroxaban21$17,339
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$12,107
FarxigaDapagliflozin Propanediol19$9,430
MyrbetriqMirabegron14$8,652
Combivent RespimatIpratropium/Albuterol Sulfate14$6,879
Breo ElliptaFluticasone/Vilanterol13$5,382
Omeprazole236$4,548
Atorvastatin Calcium396$3,680
Albuterol Sulfate HfaAlbuterol Sulfate61$2,562
Gabapentin116$2,413
Doxycycline Monohydrate110$2,187

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$147$143,52577 claims
PfizerEliquis$57$67,42955 claims
Boehringer IngelheimJardiance, Combivent Respimat$16$29,31333 claims
Lilly USA, LLCMounjaro$162$26,39416 claims
Johnson & JohnsonXarelto$238$17,33921 claims
AstraZenecaFarxiga$14$9,43019 claims
Astellas Pharma US IncMyrbetriq$17$8,65214 claims
GSKBreo Ellipta$43$5,38213 claims
AbbVieSynthroid$265$1,31613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,302 internal medicine providers in North Carolina.

Other internal medicine in Havelock

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →